RF26 RF26 (Hydrochlorothiazide 12.5 mg)
Pill imprint RF26 RF26 has been identified as Hydrochlorothiazide 12.5 mg.
Hydrochlorothiazide is used in the treatment of high blood pressure; edema; diabetes insipidus; nephrocalcinosis; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RF26 RF26
- Strength:
- 12.5 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Thiazide diuretics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Ipca Laboratories Limited
More about hydrochlorothiazide
Consumer resources
- HCTZ
- Hydrochlorothiazide
- Hydrochlorothiazide capsules
- Hydrochlorothiazide solution
- Hydrochlorothiazide (Advanced Reading)
- Other brands: Microzide, Aquazide H
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
